The demand for experienced medical writers is surging to support improvements in patient safety, transparency of clinical trials and the increasing demand for health economics and outcomes research.

To streamline operations and ensure on-time delivery of all these kinds of documents, pharma and biopharma companies often outsource medical writing to one or more vendors. However, using multiple vendors — one for clinical-trial documents, another for regulatory submissions, for example — often creates inefficiencies. That’s why many companies are looking to outsource their medical writing to just one vendor to streamline the process.

In this playbook from Cardinal Health and BioPharma Dive, we explore how a single-source model can benefit your company, including:

• Helps ensure scientific accuracy
• Offers long-term cost savings 
• Enhances your ability to scale up quickly
• Expands operational efficiency 
• Provides a higher quality of work

​